ERC Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 6 (2) 175-180    DOI: 10.1677/erc.0.0060175
Copyright © 1999 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (51)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Key, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Key, T.
Endocrine Related Cancer, Vol 6, Issue 2, 175-180
Copyright © 1999 by Society for Endocrinology


Articles

Serum oestradiol and breast cancer risk

TJ Key


Breast cancer risk is increased by early menarche and late menopause, suggesting that the long duration of exposure of the breasts to the high levels of ovarian steroids in premenopausal women increases risk. Recent prospective studies have shown that postmenopausal women who develop breast cancer have significantly greater prediagnostic serum concentrations of oestradiol than postmenopausal women who remain healthy. Estimation of long-term oestradiol concentrations in premenopausal women is difficult, and few data are available from prospective studies, but these are compatible with the hypothesis that relatively high oestradiol concentrations in premenopausal women are also associated with an increase in breast cancer risk. Women in populations with low breast cancer rates have low serum oestradiol concentrations both before and after the menopause. The serum concentration of oestradiol is probably a major determinant of breast cancer risk, but more data are needed to confirm this and to investigate the possible roles of other sex hormones.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. L. Rock, S. W. Flatt, G. A. Laughlin, E. B. Gold, C. A. Thomson, L. Natarajan, L. A. Jones, B. J. Caan, M. L. Stefanick, R. A. Hajek, et al.
Reproductive Steroid Hormones and Recurrence-Free Survival in Women with a History of Breast Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 614 - 620.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
C. Duffy, K. Perez, and A. Partridge
Implications of Phytoestrogen Intake for Breast Cancer
CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
P. W. Parodi
Dairy Product Consumption and the Risk of Breast Cancer
J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 556S - 568S.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. Dabrosin
Increased extracellular local levels of estradiol in normal breast in vivo during the luteal phase of the menstrual cycle
J. Endocrinol., October 1, 2005; 187(1): 103 - 108.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A.-S. Furberg, G. Jasienska, N. Bjurstam, P. A. Torjesen, A. Emaus, S. F. Lipson, P. T. Ellison, and I. Thune
Metabolic and Hormonal Profiles: HDL Cholesterol as a Plausible Biomarker of Breast Cancer Risk. The Norwegian EBBA Study
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. A. McDonald, M. G. Mandel, P. A. Marchbanks, S. G. Folger, J. R. Daling, G. Ursin, M. S. Simon, L. Bernstein, B. L. Strom, S. A. Norman, et al.
Alcohol Exposure and Breast Cancer: Results of the Women's Contraceptive and Reproductive Experiences Study
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2106 - 2116.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. L. Rock, S. W. Flatt, C. A. Thomson, M. L. Stefanick, V. A. Newman, L. A. Jones, L. Natarajan, C. Ritenbaugh, K. A. Hollenbach, J. P. Pierce, et al.
Effects of a High-Fiber, Low-Fat Diet Intervention on Serum Concentrations of Reproductive Steroid Hormones in Women With a History of Breast Cancer
J. Clin. Oncol., June 15, 2004; 22(12): 2379 - 2387.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. K. Bhat, G. Calaf, T. K. Hei, T. Loya, and J. V. Vadgama
Critical role of oxidative stress in estrogen-induced carcinogenesis
PNAS, April 1, 2003; 100(7): 3913 - 3918.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Forsti, Q. Jin, E. Grzybowska, M. Soderberg, H. Zientek, M. Sieminska, J. Rogozinska-Szczepka, E. Chmielik, B. Utracka-Hutka, and K. Hemminki
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer
Carcinogenesis, August 1, 2002; 23(8): 1315 - 1320.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P. E. Lonning
Aromatase inhibitors and inactivators in breast cancer
BMJ, October 20, 2001; 323(7318): 880 - 881.
[Full Text] [PDF]


Home page
JCOHome page
A. Goldhirsch, J. H. Glick, R. D. Gelber, A. S. Coates, and H.-J. Senn
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
J. Clin. Oncol., September 15, 2001; 19(18): 3817 - 3827.
[Full Text] [PDF]


Home page
Alcohol AlcoholHome page
R. G. Stevens and L. Hilakivi-Clarke
Alcohol exposure in utero and breast cancer risk later in life
Alcohol Alcohol., May 1, 2001; 36(3): 276 - 277.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.